Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Oct 19;21(20):7717.
doi: 10.3390/ijms21207717.

Osteoclast Fusion: Physiological Regulation of Multinucleation through Heterogeneity-Potential Implications for Drug Sensitivity

Kent Søe  1   2   3
Affiliations
Review

Osteoclast Fusion: Physiological Regulation of Multinucleation through Heterogeneity-Potential Implications for Drug Sensitivity

Kent Søe. Int J Mol Sci. .

Abstract

Classically, osteoclast fusion consists of four basic steps: (1) attraction/migration, (2) recognition, (3) cell-cell adhesion, and (4) membrane fusion. In theory, this sounds like a straightforward simple linear process. However, it is not. Osteoclast fusion has to take place in a well-coordinated manner-something that is not simple. In vivo, the complex regulation of osteoclast formation takes place within the bone marrow-in time and space. The present review will focus on considering osteoclast fusion in the context of physiology and pathology. Special attention is given to: (1) regulation of osteoclast fusion in vivo, (2) heterogeneity of osteoclast fusion partners, (3) regulation of multi-nucleation, (4) implications for physiology and pathology, and (5) implications for drug sensitivity and side effects. The review will emphasize that more attention should be given to the human in vivo reality when interpreting the impact of in vitro and animal studies. This should be done in order to improve our understanding of human physiology and pathology, as well as to improve anti-resorptive treatment and reduce side effects.

Keywords: CD47; DC-STAMP; denosumab; fusion; heterogeneity; osteoclast; pathology; physiology; syncytin-1; zoledronic acid.

PubMed Disclaimer

Conflict of interest statement

The author declare no conflict of interest.

Figures

Figure 1
Figure 1
Schematic representation of how heterogeneity may regulate osteoclast fusion. Dotted arrows indicate migration of pre-osteoclasts to the bone surface. Green text and arrows indicate that heterogeneity favors fusion. Red arrows, crosses, and text indicate that lack of heterogeneity reduces the likelihood of fusion.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Hernández J.M., Podbilewicz B. The hallmarks of cell-cell fusion. Development. 2017;144:4481–4495. doi: 10.1242/dev.155523. - DOI - PubMed
    1. Sims N.A., Martin T.J. Osteoclasts Provide Coupling Signals to Osteoblast Lineage Cells Through Multiple Mechanisms. Annu. Rev. Physiol. 2020;82:507–529. doi: 10.1146/annurev-physiol-021119-034425. - DOI - PubMed
    1. Delaisse J.-M., Andersen T.L., Kristensen H.B., Jensen P.R., Andreasen C.M., Søe K. Re-thinking the bone remodeling cycle mechanism and the origin of bone loss. Bone. 2020 doi: 10.1016/j.bone.2020.115628. in press. - DOI - PubMed
    1. Møller A.M.J., Delaissé J.-M., Olesen J.B., Madsen J.S., Canto L.M., Bechmann T., Rogatto S.R., Søe K. Aging and menopause reprogram osteoclast precursors for aggressive bone resorption. Bone Res. 2020;8:27. doi: 10.1038/s41413-020-0102-7. - DOI - PMC - PubMed
    1. Boissy P., Saltel F., Bouniol C., Jurdic P., huca-Gayet I. Transcriptional activity of nuclei in multinucleated osteoclasts and its modulation by calcitonin. Endocrinology. 2002;143:1913–1921. doi: 10.1210/endo.143.5.8813. - DOI - PubMed